SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-18-008556
Filing Date
2018-12-26
Accepted
2018-12-26 11:00:38
Documents
2
Period of Report
2018-12-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3354
2 EXHIBIT 24.1 exh_241.htm EX-24.1 5726
  Complete submission text file 0001171843-18-008556.txt   10271
Mailing Address
Business Address
TARNOW MICHAEL M (Reporting) CIK: 0001263647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 181251786

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations